Hyderabad: MSN Laboratories on Friday announced the introduction of Posaconazole useful in the treatment of Black Fungus (Mucormycosis) patients. This drug belongs to the fungicide Trizol category.
According to the company’s release, MSN has introduced tablets in 100 mg and injections in 300 mg capacity under the brand name Posa One. It has been found useful in the treatment of patients suffering from black fungus.
The pharmaceutical company stated, “This is a result of MSN’s research and manufacturing capability in the field of anti-fungal drugs.” The company has now set a target of making it accessible to patients across the country through its strong distribution network. ” Posa One has received approval from the Controller General of Indian Medicine.
